Anti-PSMA (124)I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle

BACKGROUND: Prostate cancer (PCa) is the second leading cause of cancer-related death in the Western population. The use in oncology of positron emission tomography/computed tomography (PET/CT) with emerging radiopharmaceuticals promises accurate staging of primary disease, restaging of recurrent di...

Descripción completa

Detalles Bibliográficos
Autores principales: Frigerio, B., Morlino, S., Luison, E., Seregni, E., Lorenzoni, A., Satta, A., Valdagni, R., Bogni, A., Chiesa, C., Mira, M., Canevari, S., Alessi, A., Figini, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651934/
https://www.ncbi.nlm.nih.gov/pubmed/31337429
http://dx.doi.org/10.1186/s13046-019-1325-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651934/
https://www.ncbi.nlm.nih.gov/pubmed/31337429
http://dx.doi.org/10.1186/s13046-019-1325-6

Ejemplares similares